OSTEOARTHRITIS INITIATIVE RELEASES FIRST DATA

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



U.S. Department of Health and Human Services 
NATIONAL INSTITUTES OF HEALTH 
NIH News 
National Institute of Arthritis and Musculoskeletal and Skin Diseases
(NIAMS) http://www.niams.nih.gov/ 
National Institute on Aging (NIA) http://www.nia.nih.gov/ 

FOR IMMEDIATE RELEASE: Tuesday, August 01, 2006

CONTACT: Ray Fleming, 301-496-8190, flemingr@xxxxxxxxxxxx 

OSTEOARTHRITIS INITIATIVE RELEASES FIRST DATA 

The Osteoarthritis Initiative (OAI), a public-private partnership
between the National Institutes of Health (NIH) and private industry
that seeks to improve diagnosis and monitoring of osteoarthritis (OA)
and foster development of new treatments, has released its first set of
data. 

Making this information available to researchers worldwide will expedite
the pace of scientific studies and identification of biological and
structural markers (biomarkers) for OA. Researchers can analyze the data
to form new hypotheses for further study of OA, which is the major cause
of activity limitation and disability in older people. Images, including
x rays and magnetic resonance imaging scans, will also be available to
researchers upon request. All data are stored with an anonymous
identification number to protect the confidentiality of the
participants' information.

"Since its inception, the OAI has been a premier example of how
industry, government, and academic sectors might work together to add
value to biomedical research," says NIH Director Elias A. Zerhouni, M.D.
"This first data release is proof positive that with cooperation, we can
achieve results that neither the government nor its private partners is
able to reach alone."

Over the next five years, the OAI will provide an unparalleled,
state-of-the-art longitudinal database of images and clinical outcome
information to facilitate the discovery of biomarkers for development
and progression of OA. In this case, a biomarker would be a physical
sign or biological substance that indicates changes in bone or
cartilage.

Nearly 5,000 people at risk of developing knee OA, in the early stage of
the disease or with more advanced knee OA are participating in the OAI
at four centers around the United States. Participants in the research
study provide biological specimens (blood, urine, and DNA); images (X
rays and magnetic resonance scans); and clinical data such as dietary
intake, medication use and pain, function, and general health
assessments.

Data gathered from participants are available to researchers at
http://www.oai.ucsf.edu. The data include symptoms; pain severity; a
measure of pain, stiffness, and function known as the WOMAC OA index;
walking ability; endurance; balance and strength; nutrition; and
prescription medicines and alternative therapies used by the
participants.  

A second set of data will be released later in 2006, and a third release
will take place early in 2007. Subsequent data will be released at
approximately six-month intervals.

The four centers taking part in the study and their principal
investigators include:

 -- The University of Maryland School of Medicine, Baltimore; Marc
Hochberg, M.D., M.P.H., in conjunction with Johns Hopkins Bayview
Medical Center; Joan Bathon, M.D. 

 -- The Ohio State University, Columbus; Rebecca Jackson, M.D. 

 -- The University of Pittsburgh; C. Kent Kwoh, M.D. 

 -- Memorial Hospital of Rhode Island , Pawtucket; Charles Eaton, M.D. 
 
The study is coordinated and the data from the study and the Web site
are managed by the University of California, San Francisco. The
principal investigator for the Data Coordinating Center is Michael
Nevitt, Ph.D.

Today, 35 million people --  13 percent of the U.S. population -- are 65
and older, and more than half of them have radiological evidence of
osteoarthritis in at least one joint. By 2030, an estimated 20 percent
of Americans -- about 70 million people - will have passed their 65th
birthday and will be at increased risk for OA. 

The OAI is a public-private partnership comprised of five contracts
funded by the National Institute of Arthritis and Musculoskeletal and
Skin Diseases (NIAMS), National Institute on Aging (NIA), Office of
Research on Women's Health (ORWH), National Institute of Dental and
Craniofacial Research (NIDCR), National Institute of Biomedical Imaging
and Bioengineering (NIBIB), National Center on Minority Health and
Health Disparities (NCMHD) and National Center for Complementary and
Alternative Medicine (NCCAM), all part of the Department of Health and
Human Services' National Institutes of Health. Private funding partners
include Merck Research Laboratories, Novartis Pharmaceuticals
Corporation, GlaxoSmithKline, and Pfizer Inc.  Private-sector funding
for the OAI is managed by the Foundation for the National Institutes of
Health.

The mission of the NIAMS is to support research into the causes,
treatment and prevention of arthritis and musculoskeletal and skin
diseases; the training of basic and clinical scientists to carry out
this research; and the dissemination of information on research progress
in these diseases. For more information about NIAMS, call the
information clearinghouse at (301) 495-4484 or (877) 22-NIAMS (free
call) or visit the NIAMS Web site at http://www.niams.nih.gov.
Information on bone and its disorders can be obtained from the NIH
Osteoporosis and Related Bone Diseases~National Resource Center; Phone
(toll free) 800-624-BONE (2663) or visit http://www.osteo.org. 

The NIA leads the Federal Government effort conducting and supporting
research on the biomedical and social and behavioral aspects of aging
and the problems of older people. For more information on aging and
aging-related research, please visit the NIA Web site at
www.nia.nih.gov. The public may also call for publications at
1-800-222-2225, the toll-free number for the National Institute on Aging
Information Center.

The Foundation for the National Institutes of Health was established by
the United States Congress to support the mission of the National
Institutes of Health - improving health through scientific discovery.
The foundation identifies and develops opportunities for innovative
public-private partnerships involving industry, academia and the
philanthropic community. A nonprofit, 501(c)(3) corporation, the
Foundation raises private-sector funds for a broad portfolio of unique
programs that complement and enhance NIH priorities and activities. The
foundation's Web site address is http://www.fnih.org.
 
The National Institutes of Health (NIH) -- "The Nation's Medical
Research Agency" -- includes 27 Institutes and Centers and is a
component of the U.S. Department of Health and Human Services. It is the
primary federal agency for conducting and supporting basic, clinical and
translational medical research, and it investigates the causes,
treatments, and cures for both common and rare diseases. For more
information about NIH and its programs, visit www.nih.gov.
  
##

This NIH News Release is available online at:
http://www.nih.gov/news/pr/aug2006/niams-01.htm.


To subscribe (or unsubscribe) from this list, go to
http://list.nih.gov/cgi-bin/wa?SUBED1=nihpress&A=1.

[Index of Archives]     [CDC News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux